Ruling Out Coronary Artery Disease and Myocardial Injury by Biomarkers | MicrobiomeTrials← Back to trialsNCT04144725
Ruling Out Coronary Artery Disease and Myocardial Injury by Biomarkers
RecruitingOBSERVATIONAL
Trial Details
Start: 2019-10-23Est. Completion: 2023-12-31
Enrollment target: 1,000 participants Locations- Akershus University Hospital, Lørenskog, Norway
Other microbiome trials you might be interested in
Mitral Valve ProlapseMitral Regurgitation
Mitral regurgitation (MR) is the second most frequent valvular heart disease and the second most frequent indication for…
Milan, ItalyEst. completion Jun 1, 2029
Myocardial Infarction (MI)
There is a knowledge gap in the literature around using watts to measure exercise intensity in walking and running, this…
Multiple LocationsEst. completion Jan 31, 2027
Coronary Artery Disease (CAD)
This randomized controlled study aims to evaluate the effects of a combined mind-body intervention consisting of progres…
Ankara, Turkey (Türkiye)Est. completion Aug 2026